Christopher Smitson
Interventional Cardiology · Fort Wayne, INNPI 1174865760
Payments from drug & device makers
What this record shows
This record is dominated by grants: $18,000 of the $24,118 with a category attached, or 74.6%. Medtronic accounts for 76.4% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $18,920 and has fallen 97.7% since, to $437 in 2025.
Across 80 payments — averaging $301.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$18K
- Edwards Lifesciences$3K
- Abiomed$512
- Abbott$457
- Shockwave Medical, Inc$319
- Chiesi USA, Inc.$276
- plus $978 from 10 others
What the payments were for
- Grants$18,00075%
- Travel & lodging$1,8998%
- Food & beverage$3,83516%
- Education$3842%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 4 | $18,432 |
| Edwards Lifesciences | 21 | $3,144 |
| Abiomed | 4 | $512 |
| Abbott | 5 | $457 |
| Shockwave Medical, Inc | 13 | $319 |
| Chiesi USA, Inc. | 4 | $276 |
| Endologix LLC | 2 | $201 |
| Terumo Medical Corporation | 4 | $161 |
| Stryker | 4 | $130 |
| Surmodics, Inc. | 4 | $120 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $103 |
| Biotronik Inc. | 3 | $89 |
| Heartflow, Inc. | 1 | $86 |
| Johnson & Johnson | 2 | $58 |
| Merck | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$18,144
- THE EDWARDS SAPIEN 3 VALVE WITH ALTERRA ADAPTIVE PRESTENT SYSTEM$1,080
- Edwards SAPIEN 3 Transcatheter Heart Valve$739
- Impella$397
- SAPIEN 3 Ultra RESILIA$236
- HeartMate$174
- COREVALVE EVOLUT R$160
- ENDOCROSS Device$152
- Torus Stent Graft System$152
- KENGREAL$131
- Resolute$127
- AMPLATZER$111
- Optis Coronary Imaging System$108
- KENGREAL 50MG/10ML L$108
How this compares
$24,118 in reported general payments places this provider in the 85th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 146 | $176,746 |
| EntrestoSacubitril/Valsartan | 89 | $108,624 |
| Repatha SureclickEvolocumab | 103 | $76,042 |
| XareltoRivaroxaban | 30 | $41,888 |
| JardianceEmpagliflozin | 35 | $40,559 |
| VascepaIcosapent Ethyl | 16 | $17,459 |
| Atorvastatin Calcium | 605 | $4,242 |
| Prasugrel Hcl | 25 | $3,582 |
| Ezetimibe | 126 | $2,938 |
| Metoprolol Succinate | 320 | $2,683 |
| ClopidogrelClopidogrel Bisulfate | 297 | $2,275 |
| Ranolazine ErRanolazine | 15 | $1,979 |
| Rosuvastatin Calcium | 258 | $1,651 |
| Carvedilol | 289 | $1,591 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 43 | $1,556 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $58 | $41,88830 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 170 interventional cardiology providers in Indiana.
Other interventional cardiology in Fort Wayne
- Muzammil MusaniFort Wayne$184K
- Vijay ChilakamarriFort Wayne$21K
- Samer AbbasEast Chicago$395K
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Dean FerreraEast Chicago$180K
- Shashidhar DivakaruniMunster$97K
- Jarrod FrizzellEvansville$86K
- Navneet LatherNoblesville$83K
- Michael BallIndianapolis$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.